Clinical importance of atrial cardiomyopathy

Int J Cardiol. 2019 Jul 15:287:174-180. doi: 10.1016/j.ijcard.2018.11.121. Epub 2018 Nov 28.

Abstract

Atrial fibrillation (AF) is the most common cause of thromboembolic complications. The risk of suffering a thromboembolic complication correlates with the CHA2DS2-VASc score identifying patients at increased risk. It is based on patient age, prior thromboembolic events, and clinical comorbidities, but not based on pathophysiological changes in different types of atrial cardiomyopathy (ACM) as classified in the expert consensus on ACM published in 2016. The impact of different types of ACM has also been acknowledged in the expert consensus statement on catheter ablation of atrial fibrillation. The aim of this review is to review data on clinical importance of ACMs.

Keywords: Anticoagulation; Fibrillation; Stroke; Therapy; Thrombogenesis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / epidemiology*
  • Atrial Fibrillation / therapy
  • Cardiomyopathies / epidemiology*
  • Cardiomyopathies / therapy
  • Catheter Ablation / methods*
  • Comorbidity
  • Global Health
  • Humans
  • Incidence
  • Risk Assessment / methods*
  • Risk Factors
  • Thromboembolism / etiology*
  • Thromboembolism / prevention & control

Substances

  • Anticoagulants